Trial Profile
Phase I safety trial of IkT 001.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2011
Price :
$35
*
At a glance
- Drugs IKT 001PRO (Primary)
- Indications Polyomavirus infections
- Focus Adverse reactions
- 24 Aug 2011 New trial record